52 related articles for article (PubMed ID: 18254717)
1. The neutral protease chymase degrades apolipoprotein E from high-density lipoproteins.
Lee-Rueckert M; von Eckardstein A; Kovanen PT
Clin Chem Lab Med; 2008; 46(3):421-3. PubMed ID: 18254717
[No Abstract] [Full Text] [Related]
2. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
Lindstedt L; Lee M; Castro GR; Fruchart JC; Kovanen PT
J Clin Invest; 1996 May; 97(10):2174-82. PubMed ID: 8636396
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Natural LCAT Mutations on the Biogenesis of HDL.
Fotakis P; Kuivenhoven JA; Dafnis E; Kardassis D; Zannis VI
Biochemistry; 2015 Jun; 54(21):3348-59. PubMed ID: 25948084
[TBL] [Abstract][Full Text] [Related]
4. [Role of tumor-associated macrophages in the regulation of protein biosynthesis in Ehrlich carcinoma cells].
Sumenkova DV; Kniazev RA; Poliakov LM; Panin LE
Vopr Onkol; 2011; 57(1):67-70. PubMed ID: 21598711
[TBL] [Abstract][Full Text] [Related]
5. Hyperinsulinemia inhibits secretion of apo AI more efficiently than secretion of apoAII and apoE (insulin and secretion of apoproteins).
Goldsztajn P; Guzdek A; Kruszelnicka-Kwiatkowska O; Guevara I; Kwaśniak M; Harwich J; Piwowarska W; Dembińska-Kieć
Z Gastroenterol; 1996 Jun; 34 Suppl 3():46-8. PubMed ID: 8767459
[No Abstract] [Full Text] [Related]
6. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
7. Distribution of tocopherol and apolipoprotein A-I immunoreactivity in rat liver chromatin.
Panin LE; Polyakov LM; Kolosova NG; Russkikh GS; Poteryaeva ON
Membr Cell Biol; 1998; 11(5):631-40. PubMed ID: 9672881
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
Zhang B; Fan P; Shimoji E; Xu H; Takeuchi K; Bian C; Saku K
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody.
Nakano T; Nagata A
J Lab Clin Med; 2003 Jun; 141(6):378-84. PubMed ID: 12819635
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I.
Yamato K; Tamasawa N; Murakami H; Matsui J; Tanabe J; Suda T; Yasujima M
Diabetes Res Clin Pract; 2005 Aug; 69(2):124-8. PubMed ID: 16005361
[TBL] [Abstract][Full Text] [Related]
12. Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes.
Bach-Ngohou K; Ouguerram K; Frénais R; Maugère P; Ripolles-Piquer B; Zaïr Y; Krempf M; Bard JM
J Pharmacol Exp Ther; 2005 Oct; 315(1):363-9. PubMed ID: 16014756
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the mysteries of high density lipoprotein metabolism.
Rudel LL; Kesäniemi AA
Curr Opin Lipidol; 1999 Aug; 10(4):293-4. PubMed ID: 10482130
[No Abstract] [Full Text] [Related]
14. Plasma lipoproteins as a transport form of extracellular DNA.
Sumenkova DV; Polyakov LM; Panin LE
Bull Exp Biol Med; 2013 Mar; 154(5):622-3. PubMed ID: 23658883
[TBL] [Abstract][Full Text] [Related]
15. Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum.
Usami Y; Matsuda K; Sugano M; Ishimine N; Kurihara Y; Sumida T; Yamauchi K; Tozuka M
J Immunol Methods; 2011 Jun; 369(1-2):51-8. PubMed ID: 21497162
[TBL] [Abstract][Full Text] [Related]
16. [Apolipoprotein E in high-density lipoprotein in patients with old cerebral infarction].
Ikeda H; Shimizu E; Maeda J; Toratani Y; Sakamoto K
Nihon Ronen Igakkai Zasshi; 1987 Nov; 24(6):561-6. PubMed ID: 3449657
[No Abstract] [Full Text] [Related]
17. Association in vivo of glycated apolipoprotein A-I with high density lipoproteins.
Calvo C; Verdugo C
Eur J Clin Chem Clin Biochem; 1992 Jan; 30(1):3-5. PubMed ID: 1576237
[TBL] [Abstract][Full Text] [Related]
18. Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3.
Benvenga S; Cahnmann HJ; Rader D; Kindt M; Robbins J
Endocrinology; 1992 Dec; 131(6):2805-11. PubMed ID: 1446618
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation of lipoproteins: chemistry and biological implications.
Flückiger R
Monogr Atheroscler; 1985; 13():53-62. PubMed ID: 3911059
[No Abstract] [Full Text] [Related]
20. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
[No Abstract] [Full Text] [Related]
[Next] [New Search]
